Clinical experience with hepatorenal tyrosinemia from a single Egyptian center
Although very recently, in Egypt, sick newborn screening has included screening for hepatorenal tyrosinemia, yet, it is not yet included in nationwide neonatal screening and hence diagnosis may be delayed. The aim of this study was to analyze data of all cases presenting with hepatorenal tyrosinemia...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089876/?tool=EBI |
| _version_ | 1818201845011578880 |
|---|---|
| author | Hanaa El-Karaksy Hala Mohsen Abdullatif Carolyne Morcos Ghobrial Engy Adel Mogahed Noha Adel Yasin Noha Talal Mohamed Rashed |
| author_facet | Hanaa El-Karaksy Hala Mohsen Abdullatif Carolyne Morcos Ghobrial Engy Adel Mogahed Noha Adel Yasin Noha Talal Mohamed Rashed |
| author_sort | Hanaa El-Karaksy |
| collection | DOAJ |
| description | Although very recently, in Egypt, sick newborn screening has included screening for hepatorenal tyrosinemia, yet, it is not yet included in nationwide neonatal screening and hence diagnosis may be delayed. The aim of this study was to analyze data of all cases presenting with hepatorenal tyrosinemia to the Pediatric Hepatology Unit, Cairo University, Egypt from 2006 to 2019. Data were retrieved from patients’ files including age of onset of symptoms, clinical signs, blood counts, liver functions, serum phosphorous, alpha-fetoprotein, succinylacetone and abdominal ultrasound. During this period, 76 patients were diagnosed with hepatorenal tyrosinemia if succinylacetone in dry blood spot was elevated above 1 μmol/L. These 76 cases came from 70 families; consanguinity was reported in 61 families. In our cohort we reported 30 affected siblings with a similar clinical presentation, who died undiagnosed. Presentation was acute in 26%, subacute in 30% and chronic in 43%. Abdominal distention was the commonest presenting symptom (52.6%). Coagulopathy was the commonest derangement in liver functions; hyperbilirubinemia and raised transaminases were less common. Ultrasound findings included hepatic focal lesions in 47% and enlarged echogenic kidneys in 39% and 45.3% respectively. Only 20 children were treated with Nitisinone because of unavailability and high costs; seven out of them underwent liver transplantation. In conclusion, although hepatorenal tyrosinemia is a rare inborn error of metabolism, in a large population country with high rate of consanguinity; this disease is not uncommonly diagnosed. The current treatment is not readily available because of the costs in a resource-limited country. Neonatal screening and subsidization of the costly medication need to be considered. |
| first_indexed | 2024-12-12T03:00:01Z |
| format | Article |
| id | doaj.art-666b138e39b64760a8f6a1da4db2a445 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-12T03:00:01Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-666b138e39b64760a8f6a1da4db2a4452022-12-22T00:40:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01175Clinical experience with hepatorenal tyrosinemia from a single Egyptian centerHanaa El-KaraksyHala Mohsen AbdullatifCarolyne Morcos GhobrialEngy Adel MogahedNoha Adel YasinNoha TalalMohamed RashedAlthough very recently, in Egypt, sick newborn screening has included screening for hepatorenal tyrosinemia, yet, it is not yet included in nationwide neonatal screening and hence diagnosis may be delayed. The aim of this study was to analyze data of all cases presenting with hepatorenal tyrosinemia to the Pediatric Hepatology Unit, Cairo University, Egypt from 2006 to 2019. Data were retrieved from patients’ files including age of onset of symptoms, clinical signs, blood counts, liver functions, serum phosphorous, alpha-fetoprotein, succinylacetone and abdominal ultrasound. During this period, 76 patients were diagnosed with hepatorenal tyrosinemia if succinylacetone in dry blood spot was elevated above 1 μmol/L. These 76 cases came from 70 families; consanguinity was reported in 61 families. In our cohort we reported 30 affected siblings with a similar clinical presentation, who died undiagnosed. Presentation was acute in 26%, subacute in 30% and chronic in 43%. Abdominal distention was the commonest presenting symptom (52.6%). Coagulopathy was the commonest derangement in liver functions; hyperbilirubinemia and raised transaminases were less common. Ultrasound findings included hepatic focal lesions in 47% and enlarged echogenic kidneys in 39% and 45.3% respectively. Only 20 children were treated with Nitisinone because of unavailability and high costs; seven out of them underwent liver transplantation. In conclusion, although hepatorenal tyrosinemia is a rare inborn error of metabolism, in a large population country with high rate of consanguinity; this disease is not uncommonly diagnosed. The current treatment is not readily available because of the costs in a resource-limited country. Neonatal screening and subsidization of the costly medication need to be considered.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089876/?tool=EBI |
| spellingShingle | Hanaa El-Karaksy Hala Mohsen Abdullatif Carolyne Morcos Ghobrial Engy Adel Mogahed Noha Adel Yasin Noha Talal Mohamed Rashed Clinical experience with hepatorenal tyrosinemia from a single Egyptian center PLoS ONE |
| title | Clinical experience with hepatorenal tyrosinemia from a single Egyptian center |
| title_full | Clinical experience with hepatorenal tyrosinemia from a single Egyptian center |
| title_fullStr | Clinical experience with hepatorenal tyrosinemia from a single Egyptian center |
| title_full_unstemmed | Clinical experience with hepatorenal tyrosinemia from a single Egyptian center |
| title_short | Clinical experience with hepatorenal tyrosinemia from a single Egyptian center |
| title_sort | clinical experience with hepatorenal tyrosinemia from a single egyptian center |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089876/?tool=EBI |
| work_keys_str_mv | AT hanaaelkaraksy clinicalexperiencewithhepatorenaltyrosinemiafromasingleegyptiancenter AT halamohsenabdullatif clinicalexperiencewithhepatorenaltyrosinemiafromasingleegyptiancenter AT carolynemorcosghobrial clinicalexperiencewithhepatorenaltyrosinemiafromasingleegyptiancenter AT engyadelmogahed clinicalexperiencewithhepatorenaltyrosinemiafromasingleegyptiancenter AT nohaadelyasin clinicalexperiencewithhepatorenaltyrosinemiafromasingleegyptiancenter AT nohatalal clinicalexperiencewithhepatorenaltyrosinemiafromasingleegyptiancenter AT mohamedrashed clinicalexperiencewithhepatorenaltyrosinemiafromasingleegyptiancenter |